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Background 
Contrast-enhanced magnetic resonance imaging (CE-MRI) is considered the gold standard imaging 
modality for suspected hip arthritis in children. A recent study at our institution identified 
discrepancies in radiological interpretation of CE-MRI hip scans and we report this separately. 
Acknowledging potential variability of reporting, we conducted the present study to explore the 
impact of CE-MRI on clinical decision-making.   
 
Methods 
We conducted a retrospective case-note review of patients who underwent hip CE-MRI at our 
Institution between January 2011 and September 2014, to confirm or exclude the presence of hip 
inflammation. The impact of CE-MRI findings on clinical management was assessed using clinic data 
and contemporaneous radiological reports. Clinical data included inflammatory markers, reported 
symptoms and medication changes before and within three months following CE-MRI. Clinician 
suspicion of inflammation or lack of it was determined if explicitly recorded by the clinician at the 
visit when CE-MRI was requested. Decision-making was based upon ĐŚĂŶŐĞƐŵĂĚĞƚŽƚŚĞƉĂƚŝĞŶƚ ?s 
treatment following CE-MRI. 
Results 
Eighty-four patients under the care of three paediatric rheumatologists and one adolescent/adult 
rheumatologist with median age of 13 years (1-16 years) were included. Twenty-two scans (26%) 
demonstrated inflammation. A significant difference (p<0.001) in treatment decisions was observed 
between those receiving an inflammatory versus non-inflammatory CE-MRI report (Table 1). 
Nineteen (86%) of the 22 patients in whom CE-MRI reported evidence of synovitis received 
increased treatment (steroid/DMARD and/or biologic drug). Clinician suspicion of inflammation or 
non-inflammation was compared against CE-MRI report (gold standard). Clinician specificity for 
inflammation was 45.8% and sensitivity 70.6%; Positive and negative predicted values were 31.6% 
and 81.5% respectively. The number of patients with an inflammatory diagnosis increased from 28 
to 42 (33% to 50%) following CE-MRI scanning.  
 
Conclusion 
CE-MRI report influenced rheumatologist decision-making. Most notably an inflammatory 
scan result was associated with increase in treatment.  
When CE-MRI was negative, clinical suspicion of inflammation had a greater impact on 
decision to treat than scan result (active inflammation of other joints may also have 
influenced decision-making). 
Clinicians were able to reliably identify non-inflamed hips.  
Clinician specificity for hip inflammation was low resulting in a high number of unnecessary 
MRI scans. 
 
 MRI Interpretation 
 Inflammation No Inflammation 
Outcome No treatment 
increase/NSAIDS 
Steroids/DMARD
s/Biologics 
No treatment 
increase/NSAIDS 
Steroids/DMARD
s/Biologics 
Clinician 
suspicion 
    
Inflammation 0  12 12 14 
Non-
inflammatory 
1 4 21 1 
Other 0 0 3 0 
Unsure 2 3 7 4 
Table 1: Treatment decisions by clinician suspicion and CE-MRI scan interpretation. Patients 
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specificity or sensitivity calculations.  
 
 
